Technology | February 24, 2011

High-Power Microwave Tissue Ablation Technology to be Shown at ECR

February 24, 2011 – A percutaneous microwave tissue ablation (pMTA) system will be unveiled at the European Congress of Radiology (ECR) in Vienna, Austria, March 4-7. The Accu2i pMTA system, from Microsulis Medical is cleared for use in Europe, the United States and Canada.

Alongside the Accu2i, Microsulis will feature case studies from key centers using the system.

It is the most powerful tissue ablation system currently available. It combines extreme ease of use with the widest range of clinical applications for rapid, precise coagulation of unwanted tissue masses, while avoiding the risks associated with longer, more invasive surgical interventions. The device is a single high power high frequency 2.45 GHz closed, water-cooled microwave needle that is 1.8 mm in diameter. It can address tissue masses more than 5 cm in size in just six minutes, making it between three and 10 times faster than other systems. Clinicians have used the device primarily in the treatment of liver and lung disease.

For more information: visit www.acculis.com

Related Content

Boston Scientific Closes Acquisition of BTG plc
News | Interventional Radiology | August 20, 2019
Boston Scientific Corp. announced the completion of its acquisition of BTG plc. pursuant to the previously announced...
Profound Medical Receives U.S. FDA 510(k) Clearance for Tulsa-Pro
Technology | Interventional Radiology | August 16, 2019
Profound Medical Corp. announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to...
FDA Clears NvisionVLE Imaging System for Pancreatic and Biliary Applications

Image courtesy of NinePoint Medical

Technology | Interventional Radiology | August 14, 2019
August 14, 2019 — NinePoint Medical Inc. announced it has received U.S.
International Multidisciplinary Group Publishes Recommendations for Personalized HCC Treatment With Y90 TheraSphere
News | Interventional Radiology | July 31, 2019
New consensus recommendations for personalized treatment for hepatocellular carcinoma (HCC) with BTG’s TheraSphere have...
WVU Medicine Installs First Alphenix 4D CT in the U.S.
News | CT Angiography (CTA) | July 24, 2019
The West Virginia University (WVU) Heart and Vascular Institute is the first hospital in the country to acquire the...
Varian Purchasing Embolic Bead Assets from Boston Scientific
News | Interventional Radiology | July 03, 2019
Varian announced it has signed an asset purchase agreement to acquire the Boston Scientific portfolio of drug-loadable...
Mentice and Siemens Healthineers Integrate VIST Virtual Patient With Artis Icono Angiography System
Technology | Interventional Radiology | June 24, 2019
Siemens Healthineers and Mentice AB announced the collaboration to fully integrate Mentice’s VIST Virtual Patient into...
DOSIsoft Receives FDA 510(k) Clearance for Planet Onco Dose Software
Technology | Information Technology | June 20, 2019
DOSIsoft announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market Planet...
Merit Medical Acquires Brightwater Medical Inc.
News | Interventional Radiology | June 19, 2019
Merit Medical Systems Inc. announced it has acquired Brightwater Medical Inc., based in Temecula, Calif. Brightwater...